When we reflect on the year that has passed, we are encouraged and pleased with everything Optimi Health has achieved. Our commitment to developing psychedelic drug candidates with strict adherence to Good Manufacturing Practices (GMP) has allowed us to reach significant production milestones, including the validation of our psilocybin extract and stability testing. These achievements have positioned Optimi in a place of strength as we look forward to advancing other drug candidates in 2024.
We hope you will take the time to go through our 2023 Annual Review which details our accomplishments as well as highlights our milestones for 2024. You can review the report by clicking on the image above or HERE.
Thank you for your continued support.
Bryan, Dane, Jacob, JJ